The Patent Finder

Terms ending in 2028

Actelion Pharmaceuticals Ltd

Every in-force patent on Actelion Pharmaceuticals Ltd's record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,044,0552-Phenyl-6-Aminocarbonyl-PYRIMIDINE Derivatives and Their Use as P2Y12 Receptor
In force
 · Medium confidence
Viatris Asia Pacific Pte. Ltd.In forceMedium confidence
US 7,868,012Sulfamides as Endothelin Receptor Antagonists for the Treatment of Cardiovascular Diseases
In force
 · High confidence
Actelion Pharmaceuticals, Ltd.In forceHigh confidence
US 8,221,978Normalization Probes for Comparative Genome Hybridization Arrays
In force
 · High confidence
Agilent Technologies, Inc.In forceHigh confidence
US 8,093,2502-Aminocarbonyl-PYRIDINE Derivatives
In force
 · High confidence
Viatris Asia Pacific Pte. Ltd.In forceHigh confidence
US 8,263,780New Process for the Preparation of 2-Imino-THIAZOLIDIN-4-ONE Derivatives
In force
 · High confidence
Vanda Pharmaceuticals Inc.In forceHigh confidence
US 8,912,340New Process for the Preparation of 2-Imino-THIAZOLIDIN-4-ONE Derivatives
In force
 · High confidence
Vanda Pharmaceuticals Inc.In forceHigh confidence
US 8,124,6235-Hydroxymethyl-OXAZOLIDIN-2-ONE-DERIVATIVES and Their Uses as Antibacterials
In force
 · High confidence
Actelion Pharmaceuticals Ltd.In forceHigh confidence
US 8,367,685Stable Pharmaceutical Compositions Comprising a Pyrimidine-Sulfamide
In force
 · High confidence
Actelion Pharmaceuticals Ltd.In forceHigh confidence
8 of 8 patents shown. Soonest term end first, then patent number.
3 of these are in force and held by Actelion Pharmaceuticals Ltd.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited